This guide explains how FDA import alert listings work for businesses in Countyline Corporate Park — the rules, the deadlines, the process and the mistakes — and how Garg Law handles them. Countyline Corporate Park, rising along the Medley–Hialeah Gardens boundary, is Miami-Dade’s newest large-scale industrial campus — modern big-box distribution space filling with grocery, consumer-product and cold-storage operations. New facilities mean new import programs, and new import programs are exactly where FDA entry review, FSVP verification and CBP targeting tend to find their first problems.
Quick answer
An import alert lets FDA detain your products automatically, shipment after shipment, without examining anything — detention without physical examination. Getting off an alert means petitioning FDA with a documented compliance record, typically including five consecutive violation-free commercial shipments, and it rarely succeeds without a rigorous, well-organized submission.
1. Overview: the regulatory framework
Import alerts are FDA’s standing instructions to its field staff: products, manufacturers, shippers or even whole countries listed on the “red list” of an alert are subject to detention without physical examination (DWPE). Once you are listed, every shipment is detained on arrival and the burden shifts to you to prove admissibility, entry after entry.
Firms are added after refusals, inspection findings, or sampling that reveals a violation — anything from salmonella in seafood to undeclared allergens, pesticide residues, or unapproved drug ingredients in supplements and cosmetics. Some alerts also carry a “green list” of firms specifically exempted; getting onto that exemption list is often the real objective.
Removal requires a petition to FDA demonstrating that the conditions giving rise to the alert have been resolved. For most commodity alerts, FDA expects evidence including a minimum of five consecutive commercial shipments entered and found compliant, plus proof of the corrective actions — supplier controls, process changes, third-party audits — that fixed the underlying problem.
2. What is at stake
DWPE converts every future shipment into a detention: bonded storage, testing costs and weeks of delay on each entry, indefinitely. For a company whose business depends on steady import flow, an unaddressed alert listing is a slow shutdown of the U.S. market.
3. Step-by-step: how the matter proceeds
- Analysis of the specific import alert, the listing basis and FDA’s published removal criteria for that alert
- A compliance roadmap: what corrective actions, testing regime and shipment history the petition will need
- Managing admissible entries while listed — per-shipment evidence packages so goods keep moving despite DWPE
- Drafting the petition for removal with the documentary record organized the way FDA’s division reviews it
- Advocacy with FDA’s import operations and compliance staff through decision, and green-list strategy where available
4. Common errors to avoid
- Shipping around the alert through new entities — FDA links related firms and the alert follows you
- Petitioning too early, before five clean consecutive shipments and corrective-action proof exist
- Submitting a disorganized petition that forces the reviewer to reconstruct your compliance story
- Treating each detention as a one-off instead of building the removal record deliberately
- Ignoring the foreign supplier’s role when the listing is supplier-based
Countyline Corporate Park: the local picture
The work around Countyline Corporate Park — regional distribution centers, food and grocery logistics, consumer products importers, cold storage, meat and produce distribution — is FDA-regulated at nearly every turn, and matters here move on the Medley–Hialeah Gardens line off the Turnpike’s Okeechobee interchange, in Miami-Dade’s newest big-box industrial corridor. Garg Law's Miami office is at 1221 Brickell Avenue, and the practice was built for exactly this market: founder Shelly Garg spent years counseling importers at the world's largest dedicated international trade law firm before opening her own, and works at the crossroads of FDA and CBP compliance for foreign and domestic companies across the food, beverage, supplement, cosmetics, OTC drug and medical device industries.
Frequently asked questions
How do I find out why my company is on an import alert?
Import alerts are published, listing firms, products and countries on each alert’s red list. The alert number on your Notice of FDA Action identifies it; the listing basis — the refusals or findings behind it — is what your removal petition must overcome.
How many clean shipments does FDA want before removal?
For most alerts FDA looks for at least five consecutive commercial shipments found compliant, typically supported by private laboratory analysis, along with evidence the root cause was corrected. Some alerts carry different or additional criteria.
How long does removal from an import alert take?
Building the shipment record takes as long as five compliant entries take to move; FDA’s review of a complete petition then commonly runs several months. A well-assembled petition avoids the added months of FDA information requests that sink sloppy ones.
Can I still import while on the red list?
Yes — DWPE means detained, not banned. Each entry can be released if you respond to the detention with satisfactory evidence, usually private lab results. It is expensive and slow, which is exactly why pursuing removal in parallel matters.
What is the green list on an import alert?
Many alerts include an exemption list — firms or products FDA has excluded from DWPE based on demonstrated compliance. A green-list exemption can protect your shipments even while an alert stays in force against your commodity or country.